Correlation Between Sarcopenia and Growth Rate of the Future Liver Remnant After Portal Vein Embolization in Patients with Colorectal Liver Metastases.
Adult
Aged
Colorectal Neoplasms
/ pathology
Embolization, Therapeutic
/ methods
Female
Humans
Liver
/ anatomy & histology
Liver Neoplasms
/ secondary
Male
Middle Aged
Organ Size
Portal Vein
/ diagnostic imaging
Retrospective Studies
Sarcopenia
/ diagnostic imaging
Tomography, X-Ray Computed
/ methods
Ultrasonography, Interventional
/ methods
FLR
Liver hypertrophy
PVE
Portal vein embolization
Sarcopenia
Journal
Cardiovascular and interventional radiology
ISSN: 1432-086X
Titre abrégé: Cardiovasc Intervent Radiol
Pays: United States
ID NLM: 8003538
Informations de publication
Date de publication:
Jun 2020
Jun 2020
Historique:
received:
18
10
2019
accepted:
09
01
2020
pubmed:
25
1
2020
medline:
24
11
2020
entrez:
25
1
2020
Statut:
ppublish
Résumé
To investigate whether sarcopenia and myosteatosis correlate with the degree of hypertrophy (DH) and kinetic growth rate (KiGR) of the future liver remnant (FLR) in patients with colorectal liver metastases undergoing portal vein embolization (PVE) in preparation for right hepatectomy. Forty-two patients were included. Total liver volume and FLR volume were measured before and 2-4 weeks after PVE. KiGR of the FLR was calculated. Sarcopenia was assessed using the total psoas muscle volume (PMV), the psoas muscle cross-sectional area (PMCS) and the total skeletal muscle index (L3SMI) at the level of 3rd lumbar vertebra. Degree of myosteatosis was assessed by mean muscle attenuation at L3 (L3MA). Correlations between muscle indices and DH and KiGR were assessed using simple linear regression analyses. Mean DH was 8.9 ± 5.7%, and mean KiGR was 3.6 ± 2.3. Mean PMV was 55.56 ± 14.19 cm We identified a positive correlation between PMV and PMCS, as markers for sarcopenia, and the KiGR of the FLR after PVE. PMV and PMCS might therefore aid to identify patients who are poor candidates for FLR augmentation using PVE alone.
Identifiants
pubmed: 31974746
doi: 10.1007/s00270-020-02416-6
pii: 10.1007/s00270-020-02416-6
pmc: PMC7225189
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
875-881Références
Am J Transplant. 2020 Feb;20(2):493-503
pubmed: 31448486
Age Ageing. 2019 Jan 1;48(1):16-31
pubmed: 30312372
Ann Surg. 2008 Jan;247(1):49-57
pubmed: 18156923
Br J Surg. 2015 Sep;102(10):1240-9
pubmed: 26109487
Eur Surg Res. 2013;51(3-4):129-37
pubmed: 24280661
J Gastrointest Surg. 2003 Mar-Apr;7(3):325-30
pubmed: 12654556
Cardiovasc Intervent Radiol. 2018 Sep;41(9):1302-1312
pubmed: 29687262
J Gastrointest Surg. 2015 Sep;19(9):1593-602
pubmed: 25925237
Dig Surg. 2012;29(1):6-17
pubmed: 22441614
J Gastrointest Surg. 2016 Jul;20(7):1317-23
pubmed: 27073080
Semin Musculoskelet Radiol. 2018 Jul;22(3):307-322
pubmed: 29791959
Liver Transpl. 2017 May;23(5):625-633
pubmed: 28240805
Ann Surg. 2005 Dec;242(6):824-8, discussion 828-9
pubmed: 16327492
Ann Surg. 2016 Feb;263(2):320-5
pubmed: 25643288
Ann Surg Oncol. 2006 Oct;13(10):1271-80
pubmed: 16955381
HPB (Oxford). 2012 Jul;14(7):461-8
pubmed: 22672548
Eur Radiol. 2019 Sep;29(9):4709-4717
pubmed: 30689036
J Am Coll Surg. 2013 Feb;216(2):201-9
pubmed: 23219349
Hepatology. 2018 Mar;67(3):1014-1026
pubmed: 29059469
Br J Surg. 2007 Nov;94(11):1386-94
pubmed: 17583900
J Cachexia Sarcopenia Muscle. 2016 May;7(2):126-35
pubmed: 27493866
Ann Surg Oncol. 2015 Aug;22(8):2663-8
pubmed: 25564158
J Surg Res. 2013 Mar;180(1):89-96
pubmed: 23149224
Eur Radiol. 2016 Dec;26(12):4259-4267
pubmed: 27090112
Br J Cancer. 2009 Feb 24;100(4):617-22
pubmed: 19209170
World J Surg. 2015 Jun;39(6):1494-500
pubmed: 25651963
Ann Surg. 2012 Nov;256(5):812-7; discussion 817-8
pubmed: 23095626